Anti-platelet factor 4 (PF4) antibodies have also been found to correlate highly with a syndrome mimicking anti-heparin-PF4-induced thrombocytopenia in COVID-19 [77,78], which has also occurred rarely following SARS-CoV-2 vaccination [74,79,80]. Here, PF4 is linked to Thrombocytopenia.